Featured Research

from universities, journals, and other organizations

Mayo Clinic Collaboration Invents 'Virus In Stealth' To Help Kill Cancer Cells

Date:
August 11, 2005
Source:
Mayo Clinic
Summary:
Mayo Clinic researchers working with colleagues in Germany have discovered a way to fight cancer by using parts of a virus found in tree shrews, small Southeast Asian mammals. The researchers used the virus to create a disguise for an engineered measles virus that enables it to sneak past the immune system. It kills cancer cells without harming healthy cells.

Mayo Clinic researchers working with colleagues in Germany havediscovered a way to fight cancer by using parts of a virus found intree shrews, small Southeast Asian mammals. The researchers used thevirus to create a disguise for an engineered measles virus that enablesit to sneak past the immune system. It kills cancer cells withoutharming healthy cells.

The work is still experimental. But it is a key step forward in thescience of redirecting or retargeting a virus through geneticengineering. Retargeted measles virus can recognize surface moleculesfound only on cancerous cells, allowing selective killing. In this way,retargeted cancer-killing viruses help the body, rather than harming itas natural viruses do when they infect cells.

In the current issue of the Journal of Virology, the researchersdescribe how they invented a way to engineer an alternative outercovering (coat) for the virus, using pieces from an animal virus thatcannot infect humans.

"Our group's perspective is to exchange pieces on the envelope, theviral coat, with the pieces from the coat of a related virus that hasno known relatives that can infect humans," says Roberto Cattaneo,Ph.D., lead researcher and an internationally recognized pioneer inviral targeting technology. "If we can modify the virus and take partsfrom the Tupaia paramyxovirus (the shrew virus) and put them on themeasles virus, then we have a virus in stealth. It will not berecognized by the immune system because it's disguised in another coat-- and that way we can get the virus past the immune system."

Significance of the Research

A different Mayo Clinic research team was the first to engineer ameasles virus retargeted at the cell entry level and reported on thisearlier this year. The current investigation takes the technology astep closer to being useful to human patients by paving the way to getthe retargeted measles virus past the immune system so it can actuallyreach the tumor and destroy it.

Background and Next Steps

Viruses are parasites. They:

* attach to, or penetrate a partner on the target cell

* fuse membranes to enter the target cell

* commandeer the cellular machinery to produce more virus

* modulate or control the host immune response

While the stealth approach works, there's a problem -- the disguiseworks only once because a healthy immune system is so good at its job,it makes antibodies against the modified viral coat and won't betricked twice. But researchers at Mayo are designing alternativedisguises.

"That means we'll have to make another coat to disguise it again,and we have already identified candidate animal viruses that can helpus do that, which means we have the prospect of using the sameretargeted measles virus with different coats," says Dr. Cattaneo.

Noting that safety is of utmost priority, Dr. Cattaneo stresses thatmultiple safeguards prevent the unintended creation of a super viruscapable of causing a new human disease.

"With this paper we really make the point that there is an untappedresource in the form of animal viruses that can be used as a source ofmodules that can be combined with human viruses to evade the immunesystem," Dr. Cattaneo says. "Our lab can do this safely because we havequite an elaborate safety system -- four levels of specificity -- thatblock, interfere and provide an emergency brake to a virus' ability tospread in normal human cells and cause illness."

Collaboration and Support

In addition to Dr. Cattaneo, the Mayo Clinic research team includesChristoph Springfeld, M.D., Dr. P.H.; and Veronika von Messling,D.V.M.; in Rochester. Collaborators in Heidelberg, Germany areChristian Tidona, Ph.D.; and Gholamreza Darai, M.D., Ph.D. The work wassupported by research grants from Mayo Foundation, the SiebensFoundation and the National Institutes of Health, and a researchscholarship from the German Research Foundation.

###

[Springfeld C. et al. Envelope targeting: hemagglutinin attachmentspecificity rather than fusion protein cleavage-activation restrictsTupaia paramyxovirus tropism. J. Virol.]


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Mayo Clinic Collaboration Invents 'Virus In Stealth' To Help Kill Cancer Cells." ScienceDaily. ScienceDaily, 11 August 2005. <www.sciencedaily.com/releases/2005/08/050811091013.htm>.
Mayo Clinic. (2005, August 11). Mayo Clinic Collaboration Invents 'Virus In Stealth' To Help Kill Cancer Cells. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2005/08/050811091013.htm
Mayo Clinic. "Mayo Clinic Collaboration Invents 'Virus In Stealth' To Help Kill Cancer Cells." ScienceDaily. www.sciencedaily.com/releases/2005/08/050811091013.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins